テキサスにおけるループス腎炎の臨床試験
テキサス内の拠点で、ループス腎炎に関する12件の研究が参加者を募集しています。
テキサス内の都市
公式研究テキスト（英語）
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Prolato Clinical Research Center, Houston
被験者募集中第2相
18歳〜100歳 · 全性別 · 2026/10/01更新 · NCT05268289Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
- Baylor College of Medicine, Houston
被験者募集中第1相
18歳〜60歳 · 全性別 · 2026/09/14更新 · NCT06975787The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
- Baylor College of Medicine Pediatric Immunology Allergy Rheumatology, Houston
被験者募集中第2相
8歳〜20歳 · 全性別 · 2026/09/14更新 · NCT05538208A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
- The University of Texas Southwestern Medical Center, Dallas
被験者募集中第2相
12歳〜70歳 · 全性別 · 2026/09/14更新 · NCT07570862RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- University of Texas MD Anderson Cancer Center, Houston
被験者募集中第1/2相
18歳〜65歳 · 全性別 · 2026/08/26更新 · NCT06121297Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
- Texas Transplant Institute, San Antonio
被験者募集中第2相
12歳〜65歳 · 全性別 · 2026/08/24更新 · NCT07053800PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
- Novel Research LLC, Bellaire
- Liberty Research Center, Dallas
- Texas Arthritis Center, El Paso
- 他5件
被験者募集中第4相
18歳〜75歳 · 全性別 · 2026/08/03更新 · NCT07611214A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
- Rheumatology Care Center, PLLC, Bellaire
- Texas Arthritis Center, El Paso
- Novel Research, LLC., Houston
- 他3件
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/07/30更新 · NCT07201129A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
- Nkarta Investigational Site, Dallas
- Nkarta Investigational Site, Houston
被験者募集中第1/2相
18歳〜75歳 · 全性別 · 2026/06/04更新 · NCT06557265Lupus Landmark Study: A Prospective Registry and Biorepository
- UT Southwestern Medical Center, Dallas
被験者募集中観察研究
18歳〜110歳 · 全性別 · 2026/04/15更新 · NCT05934149Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
- MD Anderson Cancer Center, Houston
- The University of Texas Health Science Center at Houston, Houston
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/15更新 · NCT06434363Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial
- AARA Clinical Research, Fort Worth
被験者募集中第4相
18歳〜80歳 · 全性別 · 2025/11/06更新 · NCT07225387ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。